FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 107 filers reported holding FIVE PRIME THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $563,000 | +23.2% | 33,118 | -2.8% | 0.01% | 0.0% |
Q1 2019 | $457,000 | +44.2% | 34,085 | 0.0% | 0.01% | +50.0% |
Q4 2018 | $317,000 | -33.1% | 34,085 | 0.0% | 0.00% | -33.3% |
Q3 2018 | $474,000 | -18.3% | 34,085 | -7.1% | 0.01% | -14.3% |
Q2 2018 | $580,000 | -7.9% | 36,690 | 0.0% | 0.01% | -12.5% |
Q1 2018 | $630,000 | -5.3% | 36,690 | +21.0% | 0.01% | 0.0% |
Q4 2017 | $665,000 | -50.8% | 30,333 | -8.3% | 0.01% | -50.0% |
Q3 2017 | $1,353,000 | +50.5% | 33,080 | +10.7% | 0.02% | +45.5% |
Q2 2017 | $899,000 | +3.8% | 29,872 | +24.7% | 0.01% | 0.0% |
Q1 2017 | $866,000 | -27.8% | 23,952 | 0.0% | 0.01% | -26.7% |
Q4 2016 | $1,200,000 | -4.5% | 23,952 | 0.0% | 0.02% | -6.2% |
Q3 2016 | $1,257,000 | +18.4% | 23,952 | -6.7% | 0.02% | +14.3% |
Q2 2016 | $1,062,000 | +1.8% | 25,675 | 0.0% | 0.01% | 0.0% |
Q1 2016 | $1,043,000 | -2.2% | 25,675 | 0.0% | 0.01% | 0.0% |
Q4 2015 | $1,066,000 | +135.8% | 25,675 | -12.5% | 0.01% | +133.3% |
Q3 2015 | $452,000 | -38.0% | 29,355 | 0.0% | 0.01% | -33.3% |
Q2 2015 | $729,000 | +1.2% | 29,355 | -6.8% | 0.01% | +12.5% |
Q1 2015 | $720,000 | -20.2% | 31,495 | -5.7% | 0.01% | -20.0% |
Q4 2014 | $902,000 | +135.5% | 33,395 | +2.3% | 0.01% | +100.0% |
Q3 2014 | $383,000 | -8.2% | 32,660 | +21.9% | 0.01% | 0.0% |
Q2 2014 | $417,000 | -20.9% | 26,800 | 0.0% | 0.01% | -16.7% |
Q1 2014 | $527,000 | – | 26,800 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|